Aiforia Clinical Suites

Clinical pathology solutions

In the pipeline we have different Aiforia Clinical Suites for some of the most prevalent cancers in the world: prostate, breast, lung, and more…!

The Suites are a portfolio of tools containing: a clinical viewer, platform for QC and adaptation and an AI model for diagnostic support. Explore our already CE-IVD marked tools and what’s to come!

Scroll down to read more
Aiforia Clinical AI Model for Breast Cancer; Ki67, Aiforia®️ Clinical AI Model for Lung Cancer; PD-L1, and Aiforia®️ Clinical AI Model for Breast Cancer; ER are CE-IVD marked for diagnostic use in EU and EEA countries. Aiforia’s other AI Models, Aiforia Clinical Suites and the Aiforia Create software are currently sold for research use only.

AI-assisted diagnostics for the clinical pathology workflow.

Each Clinical Suite can be seamlessly integrated into any existing lab setup: PACS, LIS, scanning, staining, scoring definitions, and more! You don’t need to adapt to start using Aiforia’s solutions, we adapt to meet your needs.

Watch this video to see how Aiforia fits into the clinical pathology workflow:

THE AIFORIA CLINICAL SUITES: AI MODELS

Explore our CE-IVD marked clinical AI models:

One of the key tools in the portfolio of our Aiforia Clinical Suites is our repertoire of clinical AI models for diagnostic support.

Clinical_ER_tab
Breast Cancer: ER

Aiforia® Clinical AI Model for Breast Cancer; ER

  • Creates a heatmap assisting the pathologist in automatically finding the critical areas of the sample.

  • Rapidly distinguishes between normal and cancerous tissue supporting the pathologist in the quick detection of tumor epithelium.

  • Automatically scores the ER positive and negative cells of epithelial origin from either WSI or selected image areas, saving the pathologist time.

  • Provides intelligent viewing as the ER AI Model enables viewing and selection of areas with high density of ER-positive cells, or hotspots, displaying the results of image analysis.

A MULTITUDE OF CLINICAL POSSIBILITIES IN A SINGLE, UNIFIED PLATFORM

Each Aiforia Clinical Suite offers the tools you need to transform your clinical workflow:

Aiforia Clinical AI Model for Diagnostic Support

  • The deep learning AI model provides fast and powerful image analysis assistance to pathologists in their diagnostic tasks
  • CE-IVD marked Aiforia Clinical AI Model for Breast Cancer: Ki67 available now
  • CE-IVD marked Aiforia Clinical AI Model for Lung Cancer: PD-L1 available now
  • Improves diagnostic accuracy, reduces bias and standardizes analysis in sample review
  • Speeds up time-consuming tasks to free up more time for rare and complex cases
  • Increasing diagnostic confidence
  • The Aiforia clinical AI model can also be used for pre- and post-analysis screening, see below for these additional features

Aiforia Clinical Suite Viewer

  • Customized to the specific disease type (i.e. for Breast Cancer, Prostate Cancer, etc.)
  • Case-centric design with focus on slide specific results
  • Enables fast and easy review with context
  • Automatically generates numerical results to a report
  • Displays AI results as masks with high precision on whole slide images 
  • Fast and easy organization of AI findings in the slide by severity

Aiforia Platform for QC and adaptation

  • An intuitive user interface in which you can easily adapt your AI model to accommodate changes if they are needed
  • Easy management and monitoring for QC and auditing purposes
  • Compliant with the FDA’s Good Machine Learning Practices (GMLP), a framework outlining best practices in software engineering and quality management of AI systems
Additionally

You can use the Aiforia Clinical AI model for:

PRE-ANALYSIS SCREENING

Improve lab and workflow efficiency

  • Automatically prioritize cases for the pathologist to focus on the most severe ones first
  • Speed up time to diagnosis and detect more cases 

POST-ANALYSIS SCREENING

Improve patient safety

  • To act as a safety net by confirming the decisions of the pathologist and alerting them to potentially suspicious findings
  • Enabling the detection of more cases and reducing potential errors

Are you ready to experience the power of AI?

We are looking for pathology labs to join us in becoming the frontrunners of AI-powered diagnostics.

Benefits

Work more efficiently

Diagnose more patients in less time and speed up case review

ic_slideincrease_white

Improve accuracy

Improve diagnostic accuracy and be confident in your decision making

ic_define_white

Reduce bias

and standardize sample review therefore democratizing care

ic_reducebias_white

Harness your full potential

Unbind yourself from time-consuming, manual and frustrating tools and processes

Free your time

Allow yourself more time to focus on rare and complex cases

ic_save time_white

Increase output

Detect more cases in less time, take on more patients

ic_output_white-1

Improve patient outcomes

Precise diagnosis permits efficient and personalized therapies to be administered

ic_patientoutcome_white

Enhance service quality

Shorten time to diagnosis and reduce missed diagnoses and misdiagnoses

ic_decisions with confidence_white

Save on cost and time

Significant time savings, 90% less hands-on time for pathologists and reduce misdiagnosis and error while improving treatment accuracy

ic_reduce costs_white

Enhance staff satisfaction

Better workload distribution can be achieved as pathologists spend less time on manual, repetitive tasks

ic_smile_white

Less time waiting

Get your diagnosis and results faster

ic_save time_white

Effective treatment

With a precise diagnosis clinicians are able to treat more effectively

ic_personalcare_white

Democratized care

Samples are reviewed consistently and efficiently ensuring everyone is treated the same

ic_collaborate remotly_white

Reduction in unnecessary interventions

Reducing missed and misdiagnosis means a reduction in the likelihood of unnecessary surgeries or procedures

ic_regression_white

ON-DEMAND WEBINAR

Aiforia’s CE-IVD marked clinical AI models for Ki67 and PD-L1

Watch this recording for an intro and demo from pathologists Dr. Laury and Dr. Sjöblom on the Aiforia® Clinical AI Model for Lung Cancer; PD-L1 and Aiforia® Clinical AI Model for Breast Cancer; Ki67. 

Watch now

Seeing is believing.
Book a free demonstration!

Book a demo